Skip to content

Planned early delivery for pregnant women with late preterm pre-eclampsia using placental growth factor testing, compared with usual care, in low- and middle-income countries

Placental growth factor testing and planned early delivery for late preterm pre-eclampsia, compared to usual care in low- and middle-income countries (PAPAGAIO-Delivery): an individualised randomised controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN71694447
Enrollment
1254
Registered
2026-02-18
Start date
2026-02-23
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy complicated by late preterm pre-eclampsia Pregnancy and Childbirth

Interventions

This is an international, multi-centre, parallel-group, individually randomised controlled trial conducted in hospitals in Sierra Leone, Zambia, India, and Brazil. Pregnant women presenting with hyper
caesarean section will be an option where indicated. Interventions – Control Group Participants allocated to the control group will receive usual care in accordance with local and international clini

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Hypertension 2. 34+0-36+6 3. Singleton pregnancy 4. Viable fetus at the time of randomisation 5. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. In labour 2. Decision to deliver within 48 hours already made (including due to indication for immediate delivery, as defined by WHO guidelines and standard local practice)

Countries

Brazil, India, Sierra Leone, Zambia

Contacts

Public ContactAlice Hurrell
PAPAGAIO@kcl.ac.uk+44 02071883634

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026